Therapeutic potential and functional interaction of carfilzomib and vorinostat in T-cell leukemia/lymphoma

We previously showed that the proteasome inhibitor carfilzomib and the histone deacetylase inhibitor (HDACI) vorinostat cooperated to induce cell apoptosis in one T-cell leukemia cell line in vitro, implying the possibility of the combination treatment of carfilzomib and vorinostat as a potential th...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Gao, Minjie, Chen, Gege, Wang, Houcai, Xie, Bingqian, Hu, Liangning, Kong, Yuanyuan, Yang, Guang, Tao, Yi, Han, Ying, Wu, Xiaosong, Zhang, Yiwen, Dai, Bojie, Shi, Jumei
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2016
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5045381/
https://ncbi.nlm.nih.gov/pubmed/27074555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8667
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires